LMND | LemonadeNYSEFinancialCommon stock golden cross and death cross projections, cross tests and history

$41.19
-$1.75 (-4.08%)

Lemonade (LMND) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat below the 200 on the daily since Apr 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
below both $41.19 vs 50 $47.63 / 200 $58.22
Projection
No cross projected
Test
No active test
Last cross
Death cross 15 Apr 2026 ยท projected 22 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $42.94 vs 50 $61.26 / 200 $34.45
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 28 Apr 2025 ยท projected 23 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $40.99 vs 50 $45.13 / 200 $53.60
Projection
No cross projected
Test
No active test
Last cross
Death cross 12 Aug 2026 ยท projected 22 bars out

Cross history

24
crosses on record since 2021
12 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
12 Aug 2026Death4-hour22 bars outNot tested
7 Jul 2026Golden4-hour17 bars outNot tested
15 Apr 2026Death steepdaily22 bars outNot tested
2 Mar 2026Death4-hour25 bars outNot tested
9 Jun 2025Golden4-hour20 bars outโ€”

About LMND

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$45.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorFinancial
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.